TYVASO for Cor pulmonale chronic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 143 adverse event reports in the FDA FAERS database where TYVASO was used for Cor pulmonale chronic.
Most Reported Side Effects for TYVASO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 124 | 23.7% | 123 | 7 |
| Dyspnoea | 69 | 13.2% | 2 | 55 |
| Pneumonia | 44 | 8.4% | 5 | 42 |
| Cough | 37 | 7.1% | 2 | 13 |
| Headache | 32 | 6.1% | 0 | 17 |
| Fluid retention | 26 | 5.0% | 1 | 23 |
| Chest pain | 22 | 4.2% | 0 | 15 |
| Dizziness | 22 | 4.2% | 0 | 12 |
| Pulmonary arterial hypertension | 21 | 4.0% | 7 | 14 |
| Anaemia | 15 | 2.9% | 0 | 13 |
| Oxygen saturation decreased | 15 | 2.9% | 1 | 11 |
| Condition aggravated | 13 | 2.5% | 1 | 10 |
| Diarrhoea | 13 | 2.5% | 1 | 7 |
| Fall | 13 | 2.5% | 0 | 11 |
| Fatigue | 13 | 2.5% | 1 | 3 |
Other Indications for TYVASO
Pulmonary arterial hypertension (273)
Product used for unknown indication (56)
Pulmonary hypertension (15)
Other Drugs Used for Cor pulmonale chronic
TREPROSTINIL (1,407)
AMBRISENTAN (879)
MACITENTAN (254)
EPOPROSTENOL (239)
BOSENTAN\BOSENTAN (238)
REMODULIN (220)
TRACLEER (101)
ILOPROST (65)
BOSENTAN (60)
VELETRI (43)